Avid Bioservices
Avid Bioservices, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States, with significant operational facilities in California. Founded in 1981, the company has established itself as a leader in the development and manufacturing of monoclonal antibodies and other biologics, catering to the needs of biotechnology and pharmaceutical companies. Avid Bioservices offers a comprehensive range of services, including process development, cGMP manufacturing, and analytical testing, all tailored to support the unique requirements of its clients. The company is recognised for its commitment to quality and innovation, which has positioned it favourably in the competitive landscape of contract development and manufacturing organisations (CDMOs). With a strong track record of successful partnerships and a focus on customer satisfaction, Avid Bioservices continues to drive advancements in biomanufacturing.
DitchCarbon Score
How does Avid Bioservices's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avid Bioservices's score of 30 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Avid Bioservices's reported carbon emissions
Avid Bioservices, headquartered in the United States, has made significant commitments towards reducing its carbon emissions, although specific emissions data for the most recent year is currently unavailable. The company has committed to achieving net-zero emissions across all scopes by 2050, with a start year of 2023. This commitment is part of their long-term strategy to address climate change and aligns with the Science Based Targets initiative (SBTi). Avid Bioservices is actively working towards these targets, having established a near-term target status of "Committed." This indicates their dedication to implementing strategies that will contribute to substantial reductions in greenhouse gas emissions over the coming decades. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, which is increasingly focusing on sustainability and environmental responsibility. While specific numerical targets or achievements in emissions reduction have not been disclosed, Avid Bioservices' commitment to net-zero emissions reflects a growing trend within the industry to prioritise climate action and sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avid Bioservices is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
